Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CEO Sells 3,428 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) CEO Matthew Klein sold 3,428 shares of PTC Therapeutics stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average...